Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Elena Croce
Observed name:
E. Croce
Institutions:
Ospedale Policlinico San Martino,
University of Turin,
University of Genoa
Observed institutions:
Ospedale Policlinico San Martino,
Ospedale Santa Corona,
University of Turin,
University of Genoa
ORCID:
0000-0002-2343-144X
Observed ORCID:
0000-0002-2343-144X
OpenAlex ID:
A5050522872
The treatment of advanced melanoma: Current approaches and new challenges
2024
·
Andrea Boutros
, Elena Croce
, et al.
·
Critical Reviews in Oncology/Hematology
·
187
Health-related quality of life in cancer patients treated with immune checkpoint inhibitors in randomised controlled trials: A systematic review and meta-analysis
2021
·
Andrea Boutros
, Marco Bruzzone
, et al.
·
European Journal of Cancer
·
57
Activity and Safety of First-Line Treatments for Advanced Melanoma: A Network Meta-Analysis
2022
·
Andrea Boutros
, Enrica Teresa Tanda
, et al.
·
European Journal of Cancer
·
50
Immunotherapy for the Treatment of Cutaneous Squamous Cell Carcinoma
2021
·
Andrea Boutros
, Federica Cecchi
, et al.
·
Frontiers in Oncology
·
39
PDF
Merkel Cell Carcinoma: An Immunotherapy Fairy-Tale?
2021
·
Enrica Teresa Tanda
, Agostina Lagodin d’Amato
, et al.
·
Frontiers in Oncology
·
31
PDF
Treatment beyond progression with anti-PD-1/PD-L1 based regimens in advanced solid tumors: a systematic review
2021
·
Francesco Spagnolo
, Andrea Boutros
, et al.
·
BMC Cancer
·
31
PDF
Influenza vaccination in cancer patients receiving immune checkpoint inhibitors: A systematic review
2021
·
Francesco Spagnolo
, Andrea Boutros
, et al.
·
European Journal of Clinical Investigation
·
29
PDF
How to Make Immunotherapy an Effective Therapeutic Choice for Uveal Melanoma
2021
·
Mariarosaria Marseglia
, Adriana Amaro
, et al.
·
Cancers
·
27
PDF
Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature
2023
·
A. Boutros
, A. Bottini
, et al.
·
ESMO Open
·
26
PDF
Immunotherapy in Adolescents and Young Adults: What Remains in Cancer Survivors?
2021
·
Enrica Teresa Tanda
, Elena Croce
, et al.
·
Frontiers in Oncology
·
12
PDF
Early discontinuation of cemiplimab in patients with advanced cutaneous squamous cell carcinoma
2023
·
Andrea Boutros
, Elena Croce
, et al.
·
Journal of Geriatric Oncology
·
9
PDF
Neoadjuvant treatments in patients with high-risk resectable stage III/IV melanoma
2020
·
Francesco Spagnolo
, Elena Croce
, et al.
·
Expert Review of Anticancer Therapy
·
7
Association between PD-1 single nucleotide gene variants and the risk of metastatic melanoma
2024
·
Andrea Boutros
, Roberta Carosio
, et al.
·
Archives of Dermatological Research
·
6
High BRAF variant allele frequency predicts poor outcomes in metastatic melanoma patients treated with BRAF/MEK inhibitors
2025
·
Michele Guida
, Benedetta Apollonio
, et al.
·
Journal of Translational Medicine
·
3
PDF
1687P Health-related quality of life in cancer patients treated with immune checkpoint inhibitors in randomized controlled trials: A systematic review and meta-analysis
2021
·
A. Boutros
, M. Bruzzone
, et al.
·
Annals of Oncology
·
1
New Melanoma Staging: Prognostic Factors
2020
·
Francesco Spagnolo
, Andrea Boutros
, et al.
·
Updates in surgery/Updates in surgery series
·
1
Pos1301 Early Combination With Belimumab Leads to Earlier Renal Response and Lower Corticosteroid Use in Lupus Nephritis Patients: Data From a Real-life Multicentric Study
2025
·
E. Croce
, C. Cruciani
, et al.
·
Annals of the Rheumatic Diseases
1141P Early discontinuation of cemiplimab in patients with advanced cutaneous squamous cell carcinoma
2023
·
E. Croce
, A. Boutros
, et al.
·
Annals of Oncology
PDF
Show more works
View as search
Works count:
18
Citation count:
516
H-index:
10
I10-index:
10
Year
Topic
Type